Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases

8 Aug 2018

Abstract excerpt

Chronological age represents the greatest risk factor for many life-threatening diseases, including neurodegeneration, cancer, and cardiovascular disease; ageing also increases susceptibility to infectious disease. Current efforts to tackle individual diseases may have little impact on the overall healthspan of older individuals, who would still be vulnerable to other age-related pathologies. However, recent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Share to Sirtuins and Resveratrol in Medicine
Share to Telomeres, Telomerase, and Senescence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30096787
DOI: 10.3390/ijms19082325

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related DiseasesPMID 30096787Read ↗

The role of mTOR in age-related diseasesSemantic proximity Read ↗

mTOR and Aging: An Old Fashioned DressSemantic proximity Read ↗

mTOR Signaling from Cellular Senescence to Organismal AgingSemantic proximity Read ↗

Therapeutic interventions for aging: the case of cellular senescenceSemantic proximity Read ↗

Targeting Cellular Senescence: Pathophysiology in Multisystem Age-Related DiseasesSemantic proximity Read ↗

The mTOR–lysosome axis at the centre of ageingSemantic proximity Read ↗

mTOR as a central regulator of lifespan and agingSemantic proximity Read ↗

Clinical Trials Targeting AgingSemantic proximity Read ↗

Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging InterventionsSemantic proximity Read ↗

Coming of age: molecular drivers of aging and therapeutic opportunitiesSemantic proximity Read ↗

New Trends in Aging Drug DiscoverySemantic proximity Read ↗

Senescent Cells: Emerging Targets for Human Aging and Age-Related Diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.